fbpx

Big Drop in Youth Vaping Thanks to COVID School Closures

While virtual learning during the pandemic has many drawbacks — social isolation and dependence on strong self-motivation, to start — it has at least one notable benefit. A recent government report, completed by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), revealed that youth vaping dropped significantly last year.

Youth Vaping Statistics

Health officials ask that readers use caution as they look at the numbers. Outside experts, however, believe that the decrease is real and makes sense, given that vaping is often done socially. In the national survey, 11 percent of high school students and less than 3 percent of middle school students reported that they had recently used e-cigarettes. These numbers show a 40 percent drop from last year, when almost 20 percent of high schoolers and 5 percent of middle schoolers admitted to recently vaping.

“They found a dramatic drop from last year, and it’s hard to image that doesn’t represent a real decrease in use [among students],” said Dr. Nancy Rigotti of Harvard University, who was not involved in the research. The decline needs to be confirmed by other surveys this year. There is, of course, the fear that the numbers could increase again with many in-person classes back in session. 

If these results prove true, it would be the second big drop in a row. Reporting in 2019 resulted in a peak of 28 percent for high school students. 

New Federal Restrictions for Youth Vaping

Prior to the pandemic, government restrictions began to limit the underage use of e-cigarettes. Towards the end of 2019, the purchase age for all tobacco and vaping products changed from 18 to 21. Then, the FDA banned nearly all of the flavors for cartridge-based e-cigarettes, which first ignited the popularity of teen vaping. Additionally, some kids stopped using e-cigarettes after an uptick in vaping-related illnesses and deaths. Many of these health concerns were related to a filler in black market vaping liquids that contained THC. 

Despite this promising report, government officials believe that roughly two million U.S. teens and pre-teens are still vaping — a number that is much too high. “E-cigarette use among youth remains a serious public health concern,” said CDC specialist Dr. Karen Hacker. In an effort to combat this crisis, the FDA is expected to place even bigger limits on the vaping industry and remove more products from market.

For more information about the investigation into e-cigarettes, contact us today.

Additional Reading:

FDA Requests More Time to Determine Ruling About E-Cigarettes

FDA Removes 55,000 Flavored Vaping Products From Market

North Carolina Takes Legal Action Against JUUL

JUUL Labs Faces “Substantive Scientific Review” from the FDA

E-Cigarette, Vaping, and Juul Bans

Tracy Everhart is the Editor for Drug Law Journal. A highly-trained and certified medical professional, Tracy is also an accomplished medical writer. After spending years on the front lines of the medical profession, Tracy now devotes her expertise and skills to researching and reporting on new drugs and devices that enter the market, as well as their side-effects and the real-life stories involved. Prior to joining Drug Law Journal, Tracy wrote for benchmark online healthcare resources focused on families and, in particular, women’s health issues. Tracy holds post-graduate degrees from both the American College of Healthcare Sciences and the Yale School of Nursing. She is also a graduate of both Hampshire College, where she studied microbiology and the University of South Carolina school of nursing.

Drug Law Journal Legal Sponsorship

Drug Law Journal's publishing and research are sponsored by the DDP Injury Law Group in Washington, D.C. Their legal team is focused on protecting the rights of injury victims.
Furthermore, they understand and appreciate the importance of a trusted attorney-client relationship.
The DDP Injury Law Group uses their years of experience with litigation to ensure their clients can fight for the compensation they deserve.

Always seek the advice of a medical professional when making personal health choices.

The Offices of DrugLawJournal.com are located at:

1800 North Orange Avenue, Suite C
Orlando, Florida 32804

DrugLawJournal.com is sponsored by the DDP Injury Law Group, and therefore may be considered attorney advertising. The information contained on DrugLawJournal.com is provided for informational purposes only, and should not be construed as legal or medical advice on any subject matter. No viewers of this site should discontinue taking a prescribed medication on the basis of any information on this site and should always first consult with a doctor concerning any medication. Viewers should understand that if they refrain from taking prescribed medication without appropriate medical advice they can suffer injury or death.

No viewers of content from this site, clients or otherwise, should act or refrain from acting on the basis of any content included in the site without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from an attorney licensed in the viewer’s state. Viewing information from DrugLawJournal.com does not create an attorney-client relationship between you and DDP Injury Law Group or DrugLawJournal.com nor is it intended to do so.The content of DrugLawJournal.com may not reflect current legal developments, verdicts or settlements. Prior results do not predict a similar outcome. For more information, please visit our web site’s disclaimer.

©2024 DrugLawJournal.com | Privacy Policy | Terms & Conditions

Stay Informed

Sign up to receive peroidic updates from our expert team of researchers, highlighting defective drugs, devices, and legal issues related to your health.

Email Catcher
Free Drug and Medical Device Case Review

Free Drug and Medical Device Case Review

Share your story with us and we will reach out to you about your case.

First
Last
Described what happened to you, we will review and reach out to you about your situation.

It is important for those who have suffered injury from dangerous drugs and medical devices to know that they have may have options.

Consumers have the ability to seek legal remedies for their injuries resulting from the negligence of drug and device manufacturers. The first step toward justice and recovery is sharing your story with effective legal counsel. An attorney will help you to better understand the issues and discuss the possibility of compensation for your suffering.

Once you complete the information request above, Drug Law Journal will send the information to a specialist at our legal sponsor’s firm, the DDP Injury Law Group, in Washington, D.C. That specialist will follow-up with you directly to gather further specific information about your case and make an evaluation. If the firm is able to move forward on your case, they will also discuss next steps. Remember – the entire consult and evaluation is free to you. You only need to take the first step to fill out the contact form or call: (800) 597-1870 for immediate assistance.